180 related articles for article (PubMed ID: 35458776)
1. Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation.
Chiaverini L; Pratesi A; Cirri D; Nardinocchi A; Tolbatov I; Marrone A; Di Luca M; Marzo T; La Mendola D
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458776
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections.
Cassetta MI; Marzo T; Fallani S; Novelli A; Messori L
Biometals; 2014 Aug; 27(4):787-91. PubMed ID: 24820140
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt
Tolbatov I; Cirri D; Marchetti L; Marrone A; Coletti C; Re N; La Mendola D; Messori L; Marzo T; Gabbiani C; Pratesi A
Front Chem; 2020; 8():812. PubMed ID: 33195032
[TBL] [Abstract][Full Text] [Related]
4. Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp.
She P; Liu Y; Wang Y; Tan F; Luo Z; Wu Y
J Appl Microbiol; 2020 Jan; 128(1):88-101. PubMed ID: 31509623
[TBL] [Abstract][Full Text] [Related]
5. Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN
Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605
[TBL] [Abstract][Full Text] [Related]
6. Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
Aguinagalde L; Díez-Martínez R; Yuste J; Royo I; Gil C; Lasa Í; Martín-Fontecha M; Marín-Ramos NI; Ardanuy C; Liñares J; García P; García E; Sánchez-Puelles JM
J Antimicrob Chemother; 2015 Sep; 70(9):2608-17. PubMed ID: 26142477
[TBL] [Abstract][Full Text] [Related]
7. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.
Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Hedrick VE; Paul LN; Seleem MN
Sci Rep; 2016 Mar; 6():22571. PubMed ID: 26936660
[TBL] [Abstract][Full Text] [Related]
9. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
[TBL] [Abstract][Full Text] [Related]
10. Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model.
Mohammad H; Abutaleb NS; Seleem MN
Sci Rep; 2020 Apr; 10(1):7251. PubMed ID: 32350417
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics.
Liu Y; Lu Y; Xu Z; Ma X; Chen X; Liu W
Drug Discov Today; 2022 Jul; 27(7):1961-1973. PubMed ID: 35192926
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
[TBL] [Abstract][Full Text] [Related]
14. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
Cirri D; Massai L; Giacomelli C; Trincavelli ML; Guerri A; Gabbiani C; Messori L; Pratesi A
Dalton Trans; 2022 Sep; 51(35):13527-13539. PubMed ID: 36000524
[TBL] [Abstract][Full Text] [Related]
16. Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.
Marzo T; Cirri D; Pollini S; Prato M; Fallani S; Cassetta MI; Novelli A; Rossolini GM; Messori L
ChemMedChem; 2018 Nov; 13(22):2448-2454. PubMed ID: 30252208
[TBL] [Abstract][Full Text] [Related]
17. Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori.
Owings JP; McNair NN; Mui YF; Gustafsson TN; Holmgren A; Contel M; Goldberg JB; Mead JR
FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27279627
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.
Fuchs BB; RajaMuthiah R; Souza AC; Eatemadpour S; Rossoni RD; Santos DA; Junqueira JC; Rice LB; Mylonakis E
Future Med Chem; 2016; 8(2):117-32. PubMed ID: 26808006
[TBL] [Abstract][Full Text] [Related]
19. Effect of auranofin and other gold complexes on the activity of phospholipase C.
Snyder RM; Mirabelli CK; Clark MA; Ziegler JT; Crooke ST
Mol Pharmacol; 1987 Sep; 32(3):437-42. PubMed ID: 3118179
[TBL] [Abstract][Full Text] [Related]
20. Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.
Hokai Y; Jurkowicz B; Fernández-Gallardo J; Zakirkhodjaev N; Sanaú M; Muth TR; Contel M
J Inorg Biochem; 2014 Sep; 138():81-88. PubMed ID: 24935090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
